InvestorsHub Logo
Followers 16
Posts 1772
Boards Moderated 0
Alias Born 09/05/2017

Re: None

Thursday, 12/05/2019 6:03:56 PM

Thursday, December 05, 2019 6:03:56 PM

Post# of 474100
Has anyone commented on the fact that BIIB management presented its Phase 3 aducanumab data today.

That is NOT normal. My experience is that the principal investigators present the data NOT management.

This is actually full credit to Missling. Although he isn't presenting phase 3 data tomorrow night (so it's not exactly apples to apples) it seems to me that Ariana is the lead presenter and not Missling.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News